Frontiers in Pharmacology (Jun 2024)
Erratum: Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors
Abstract
No abstracts available.Keywords